US-India IPR spat puts spotlight back on 3(d) and TRIPS divide | PharmaBoardroom
written on 27.02.2014
Tags:
,

US-India IPR spat puts spotlight back on 3(d) and TRIPS divide

TAGS: ,

Escalating tensions between the US and India over intellectual property rights (IPR) issues have put the spotlight back on provisions such as the controversial Section 3(d) of India's Patent Act and the differing views of the developed and developing…

Latest Report